Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2018-214539
PubMed Identifier: 30878974
Publication URI: http://europepmc.org/abstract/MED/30878974
Type: Journal Article/Review
Volume: 78
Parent Publication: Annals of the rheumatic diseases
Issue: 6
ISSN: 0003-4967